Dr Ever Grech

MB, BS, MD, FRCP, FACC

Department of Infection, Immunity and Cardiovascular Disease

Honorary Senior Clinical Lecturer

TAVI Lead

Hon. Senior Lecturer

Ever.Grech@sth.nhs.uk
+44 114 305 2825

Full contact details

Dr Ever Grech
Department of Infection, Immunity and Cardiovascular Disease
South Yorkshire Cardiothoracic Centre, Sam Fox House
Northern General Hospital
Herries Road
Sheffield
S5 7AU
Profile

I have been a Consultant Cardiologist since 1999 and have a wealth of experience in percutaneous coronary intervention (PCI) and transcatheter aortic valve implantation (TAVI).

Research interests

Research Interests

My research interests are diverse and clinically orientated. I have been closely involved in a number of Cardiology research projects which have resulted in a publication in a wide variety of journals as well as the award of University of Sheffield degrees.

I have also published two editions of ABC of Interventional Cardiology (BMJ Books) and three editions of Practical Interventional Cardiology (CRC Press) textbooks. I am currently involved in research projects investigating microvesicles following reperfusion after acute myocardial infarction in man.

Current Projects

I am currently involved in a research project investigating activation markers, inflammatory agents and myocardial ischemia/reperfusion injury following primary PCI recanalisation after acute myocardial infarction in man. I am also Principle Investigator for two ongoing multicentre TAVI trials (UK TAVI and ENVISAGE-AF).

Key publications
  1. Lloyd A, Steele L, Fotheringham J, Iqbal J, Sultan A, Teare MD, Grech ED. Pronounced increase in risk of acute ST-segment elevation myocardial infarction in younger smokers. (Accompanied by leading editorial and press release). Heart. 2017;103:586-91.

  2. Steele L, Lloyd A, Fotheringham J, Sultan A, Iqbal J, Grech ED. The impact of smoking on mortality after acute ST-elevation MI treated with primary percutaneous coronary intervention: a retrospective cohort outcome study at three years. J Throm Thrombolysis 2019;47:520-6.

  3. Gosai JN, Charalampidis P, Nikolaidou T, Parviz Y, Morris PD, Channer KS, Jones TH, Grech ED. Revascularization with percutaneous coronary intervention does not affect androgen status in males with chronic stable angina pectoris. Andrology 2016;4:486-91.

  4. Steele L, Lloyd A, Fotheringham J, Sultan A, Iqbal J, Grech ED. A retrospective cross-sectional study on the association between tobacco smoking and incidence of ST-segment elevation myocardial infarction and cardiovascular risk factors. Postgrad Med J 2015;91:492-6.

  5. Parviz Y, Gul H, Smith S, Grech ED. Calculating the overall risk of within-stent restenosis after multi-lesion percutaneous coronary intervention. Advances in Interventional Cardiology 2013;2(32):170-1.

  6. Palmer J, Lloyd A, Steele L, Fotheringham J, Teare D, Iqbal J, Grech ED. Differential risk of ST-segment elevation myocardial infarction in male and female smokers. (Accompanied by editoral, podcast and press release) J Am Coll Cardiol 2019;73: 3259-66.

  7. Steele L, Palmer J, Lloyd A, Fotheringham J, Iqbal J, Grech ED. Impact of socio-economic status on survival following ST-elevation myocardial infarction in a universal healthcare system. Int J Cardiol 2019;276:26-30.